Ursodeoxycholic acid and COVID-19 outcomes: a cohort study and data synthesis of state-of-art evidence.

Yang YuGuo-Fu LiJian LiLu-Yao HanZhi-Long ZhangTian-Shuo LiuShu-Xin JiaoYu-Wei QiaoNa ZhangDe-Chuan ZhanShao-Qiu TangGuo Yu

Published in: Expert review of anti-infective therapy (2024)

UDCA treatment notably improves the recovery time following an Omicron strain infection without observed safety concerns. These promising results advocate for UDCA as a viable treatment for COVID-19, paving the way for further large-scale and prospective research to explore the full potential of UDCA.

Keyphrases

coronavirus disease
sars cov
type diabetes
metabolic syndrome
electronic health record
hiv infected
adipose tissue
combination therapy
risk assessment
climate change
respiratory syndrome coronavirus
artificial intelligence
human health
glycemic control